HomeCHRS • NASDAQ
add
Coherus Biosciences Inc
Previous close
$2.08
Day range
$2.08 - $2.14
Year range
$1.43 - $5.63
Market cap
244.94M USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 77.06M | 137.58% |
Operating expense | 74.40M | -6.66% |
Net income | 102.88M | 235.85% |
Net profit margin | 133.49 | 157.18% |
Earnings per share | -0.32 | 60.00% |
EBITDA | -30.42M | 51.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 259.78M | 102.81% |
Total assets | 763.54M | 89.74% |
Total liabilities | 845.39M | 41.15% |
Total equity | -81.84M | — |
Shares outstanding | 114.73M | — |
Price to book | -2.89 | — |
Return on assets | -11.46% | — |
Return on capital | -23.24% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 102.88M | 235.85% |
Cash from operations | -46.77M | 31.96% |
Cash from investing | 202.76M | 1,056.93% |
Cash from financing | 887.00K | -76.68% |
Net change in cash | 156.88M | 430.96% |
Free cash flow | 3.97M | 108.52% |
About
Founded
2010
Headquarters
Website
Employees
249